9.2 Glomerular Disorders: Minimal Change Nephrotic Syndrome & Acute Post-Streptococcal Glomerulonephritis

Glomerular Disorders: Minimal Change Nephrotic Syndrome & Acute Post-Streptococcal Glomerulonephritis

Quick Overview: Pediatric glomerular diseases are classically divided into nephrotic syndromes (characterized by non-inflammatory podocyte injury and massive selective proteinuria) and nephritic syndromes (characterized by acute glomerular inflammation, capillary occlusion, hematuria, and hypertension). On the ANCC PED-BC examination, differentiating Minimal Change Nephrotic Syndrome (MCNS) from Acute Post-Streptococcal Glomerulonephritis (APSGN) is one of the highest-yield diagnostic comparisons. Nurses must rapidly distinguish between the hypovolemic, frothy-urine presentation of nephrotic syndrome and the hypervolemic, cola-colored hematuric presentation of post-streptococcal glomerulonephritis to initiate lifesaving medical and fluid protocols.

---

1. High-Yield Comparative Analysis: Nephrotic vs. Nephritic (APSGN)

Mastering this comparative table enables rapid differentiation of both conditions across exam stems and clinical bedside encounters:

---

2. Minimal Change Nephrotic Syndrome (MCNS)

Minimal Change Disease, also referred to as idiopathic nephrotic syndrome of childhood, accounts for 85% of all nephrotic syndrome cases in pediatric patients.

Pathophysiology

The underlying mechanism is rooted in immune dysregulation, predominantly involving circulating cytokines released by perturbed T-lymphocytes. These cytokines exert two catastrophic effects on the glomerular filtration barrier:

1. Loss of Negative Electrostatic Charge: The normal glomerular basement membrane (GBM) is lined with polyanionic heparan sulfate proteoglycans that repel negatively charged plasma proteins (such as serum albumin). Cytokines neutralize these charges, stripping the electrical barrier.
2. Podocyte Effacement: Cytokines induce diffuse flattening, retraction, and effacement of the visceral epithelial foot processes (podocytes). Under electron microscopy, the slit diaphragms disappear, transforming the filtration barrier into a highly porous mesh that permits massive filtration of albumin into Bowman's capsule (selective proteinuria).

The Classic Clinical Tetrad

Classic Tetrad of Minimal Change Nephrotic Syndrome:
├── 1. Massive Proteinuria (Urine dipstick 3+ to 4+; >50 mg/kg/day or UPCR >2.0)
├── 2. Severe Hypoalbuminemia (Serum albumin <2.5 g/dL, often <1.5 g/dL)
├── 3. Profound Generalized Edema (Periorbital, dependent, scrotal/labial, ascites)
└── 4. Hyperlipidemia (Compensatory hepatic synthesis; cholesterol >250-500 mg/dL)

1. Massive Proteinuria: Urine protein excretion exceeds 50 mg/kg/day (or spot urine protein-to-creatinine ratio [UPCR] > 2.0 mg/mg; normal < 0.2). Urine dipstick reads 3+ (300 mg/dL) or 4+ (≥1000 mg/dL). High albumin content creates high surface tension, producing frothy, bubbly, foamy urine.
2. Severe Hypoalbuminemia: Serum albumin plummets below 2.5 g/dL, often reaching profound lows of 1.0 to 1.8 g/dL.
3. Profound Generalized Edema: Severe hypoalbuminemia dramatically reduces intravascular plasma oncotic (colloid osmotic) pressure. Following Starling's principles, fluid shifts from the intravascular circulation into the interstitial spaces. Edema begins insidiously as morning puffiness around the eyes (periorbital edema, frequently misdiagnosed as seasonal allergies) and progresses downward during the day to involve the ankles, presacral area, labia/scrotum, and peritoneal cavity (ascites).
4. Hyperlipidemia: Falling oncotic pressure and low albumin stimulate the liver to accelerate non-specific protein synthesis, churning out lipoproteins (cholesterol, triglycerides, LDL, VLDL). Concurrently, urinary loss of lipoprotein lipase impairs lipid breakdown, driving total cholesterol above 250 to 500 mg/dL.

Medical & Pharmacological Management

• First-Line Corticosteroid Protocol: Prednisone or Prednisolone at 2 mg/kg/day (or 60 mg/m²/day; maximum single dose: 60 mg/day) administered orally as a single daily morning dose for 6 consecutive weeks, followed by 1.5 mg/kg on alternate days (alternate-day therapy) for 6 weeks, followed by a gradual taper.
• Steroid Responsiveness: Over 85% to 90% of children achieve complete remission (defined as urine protein negative or trace for 3 consecutive days) within 2 to 4 weeks of therapy.
• Relapse Management: 60% to 70% of initial responders experience one or more relapses, typically triggered by viral upper respiratory infections. Parents are educated to perform daily morning first-void urine dipsticks at home. A relapse is diagnosed when urine protein tests 3+ or 4+ for 3 consecutive days.
• Steroid-Resistant / Dependent Disease: Children who fail to respond within 4 weeks (steroid-resistant) or who relapse during tapering require secondary immunosuppressive agents: Calcineurin inhibitors (Cyclosporine, Tacrolimus), Mycophenolate mofetil (MMF), or Rituximab (anti-CD20 monoclonal antibody).
• Indications for Renal Biopsy: Biopsy is NOT indicated initially in typical presentation (age 2–7 years with pure nephrotic syndrome). Biopsy is strictly indicated if: age <1 year or >10–12 years, persistent gross hematuria, sustained hypertension, depressed complement C3, renal insufficiency (elevated creatinine), or steroid resistance (to evaluate for Focal Segmental Glomerulosclerosis [FSGS]).

Critical Nursing Complications of MCNS

1. Severe Bacterial Infection & Sepsis (Primary Cause of Mortality):
   • Pathophysiological cause: Massive urinary loss of immunoglobulins (IgG) and alternative complement factors (Factor B and properdin), combined with iatrogenic immunosuppression from high-dose corticosteroids.
   • Encapsulated Organism Susceptibility: Extreme vulnerability to Streptococcus pneumoniae, resulting in spontaneous bacterial peritonitis (SBP), pneumococcal bacteremia/sepsis, and pneumonia; also susceptible to Haemophilus influenzae and Escherichia coli.
   • Nursing Mandate: Any fever (temperature ≥38.0°C / 100.4°F), abdominal pain, rebound tenderness, or signs of shock requires immediate medical evaluation, blood and peritoneal cultures, and rapid initiation of broad-spectrum IV antibiotics (e.g., Cefotaxime or Ceftriaxone).
   • Immunization Rules: Administer pneumococcal conjugate and polysaccharide (PPSV23) vaccines when in remission. LIVE ATTENUATED VACCINES (MMR, Varicella, Live Flu Nasal Spray) ARE STRICTLY CONTRAINDICATED while the child is on daily high-dose immunosuppressive corticosteroid therapy!
2. Thromboembolism:
   • Hypercoagulable State: Intravascular dehydration causes hemoconcentration (elevated hematocrit and platelet count), while urinary excretion strips anticoagulant proteins (antithrombin III, protein C, and protein S). Concurrently, the liver increases production of fibrinogen (factors V and VIII).
   • Sites of Thrombi: Deep vein thrombosis (DVT), pulmonary embolism (PE), sagittal sinus thrombosis, and renal vein thrombosis (RVT) (manifested by sudden severe flank pain, gross hematuria, rapid oliguria, and a palpable kidney mass).
   • Nursing care: Avoid deep femoral venipunctures, promote age-appropriate ambulation, and avoid severe fluid restriction.
3. Severe Edema Management:
   • Dietary sodium restriction (no added salt, avoidance of cured meats and processed foods) during active edema.
   • For refractory, life-threatening edema causing respiratory compromise, scrotal skin breakdown, or severe ascites: Infusion of 25% IV Albumin (0.5 to 1.0 g/kg administered over 2 to 4 hours) followed immediately by IV Furosemide (1 to 2 mg/kg) during or at the end of the infusion. Critical nursing alert: Rapid albumin infusion can precipitate acute circulatory fluid overload, hypertension, and pulmonary edema; monitor vitals every 15 to 30 minutes.

---

3. Acute Post-Streptococcal Glomerulonephritis (APSGN)

Acute Post-Streptococcal Glomerulonephritis (APSGN) is the most common post-infectious glomerular disorder in childhood, representing an immune-complex-mediated inflammatory nephritis.

Etiology & Latent Period

APSGN follows an infection caused by nephritogenic strains of Group A Beta-Hemolytic Streptococcus (GABS, Streptococcus pyogenes) (such as M-types 1, 4, 12 following pharyngitis, and M-types 2, 49, 55 following pyoderma).

• Post-Pharyngitis Latent Period: 1 to 3 weeks (average 10 to 14 days) following streptococcal pharyngitis ("strep throat").
• Post-Pyoderma Latent Period: 3 to 6 weeks following streptococcal impetigo or cutaneous skin infection.
• High-Yield Clinical Distinction: Glomerulonephritis is NOT an active bacterial infection of the kidney; it is a delayed type III immune-complex hypersensitivity reaction. Early treatment of strep throat with penicillin does not completely prevent APSGN!

Pathophysiology & Structural Injury

1. Nephritogenic streptococcal antigens (specifically streptococcal pyrogenic exotoxin B [SPEB] and nephritis-associated plasmin receptor [NAPlr]) form circulating immune complexes with host IgG antibodies.
2. These immune complexes deposit along the subepithelial surface of the glomerular basement membrane, visible on electron microscopy as characteristic subepithelial electron-dense "humps".
3. Entrapped immune complexes activate the alternative complement cascade, consuming circulating complement factor C3. Complement fragments (C3a, C5a) recruit neutrophils and monocytes.
4. Diffuse endothelial and mesangial cellular proliferation occludes the glomerular capillary lumens. The glomerular filtration rate (GFR) drops precipitously, leading to marked retention of sodium and water, expansion of extracellular fluid volume, circulatory congestion, and leakage of erythrocytes into the renal tubules.

Clinical Presentation (The Nephritic Syndrome)

• Gross Hematuria: Hallmark clinical feature present in 30% to 50% of cases. Described as "tea-colored", "cola-colored", "smoky", or rust-colored urine. The abnormal color is caused by the oxidation of red blood cells to acid hematin in acidic tubular urine.
• Oliguria: Abrupt drop in urine output (<0.5 to 1.0 mL/kg/hour) secondary to depressed GFR.
• Acute Hypertension: Present in 60% to 80% of children, ranging from mild elevation to severe hypertensive crisis due to intravascular sodium and water expansion.
• Periorbital & Facial Edema: Fluid accumulation is most prominent around the eyes upon awakening in the morning, gradually improving as the child stands and fluid redistributes.
• Circulatory Congestion & Fluid Overload: Manifested by tachypnea, orthopnea, bibasilar pulmonary crackles, tachycardia, gallop rhythm (S3), and elevated jugular venous pressure.

Diagnostic Evaluation & Complement Trajectory

1. Urinalysis: Shows gross hematuria with dysmorphic red blood cells, characteristic red blood cell casts (confirming glomerular bleeding), mild-to-moderate proteinuria (1+ to 2+), and elevated urine specific gravity (>1.020).
2. Evidence of Prior Streptococcal Infection:
   • Elevated or rising Antistreptolysin O (ASO) titer (>200 to 400 IU/mL; peaks at 3 to 5 weeks post-pharyngitis; less sensitive for cutaneous impetigo).
   • Anti-DNase B (anti-deoxyribonuclease B) and antihyaluronidase (AHT): Extremely sensitive markers for antecedent streptococcal skin infections (impetigo).
3. Serum Complement C3 (THE DIAGNOSTIC HALLMARK):
   • Serum complement C3 is markedly DEPRESSED (<80 mg/dL) during the acute phase in over 90% of patients due to alternative complement pathway activation.
   • Trajectory Benchmarking: Complement C3 levels MUST return to normal within 6 to 8 weeks.
   • Exam Critical Alert: If serum C3 remains depressed beyond 8 to 12 weeks, the diagnosis of APSGN is refuted; the child requires a percutaneous renal biopsy to evaluate for Membranoproliferative Glomerulonephritis (MPGN) or Systemic Lupus Erythematosus (SLE) nephritis!
4. Renal Function Tests: Elevated blood urea nitrogen (BUN) and serum creatinine, mild metabolic acidosis, and transient hyperkalemia during the oliguric phase.

Medical & Nursing Management of APSGN

APSGN is a self-limiting disease with complete recovery occurring in >95% of pediatric cases. Treatment is strictly supportive:

• Fluid Balance & Strict Daily Weights:
  • Weigh the child daily at the same time on the same scale.
  • Fluid Restriction Calculation: Daily restricted fluid volume is calculated as: Insensible fluid loss (~300 to 400 mL/m²/day, or approximately 30% of normal maintenance) PLUS the previous 24-hour urine output and any other measured gastrointestinal losses (emesis/diarrhea).
• Dietary Sodium & Potassium Restriction:
  • Low-sodium diet (no added salt) to reduce fluid retention.
  • Dietary potassium restriction during the oliguric phase to prevent fatal cardiac arrhythmias.
• Antihypertensive Pharmacotherapy:
  • Loop Diuretics (IV or oral Furosemide 1 to 2 mg/kg/dose): First-line therapy to rapidly mobilize retained fluid, induce brisk diuresis, and relieve hypertension.
  • Antihypertensives: Calcium channel blockers (oral Nifedipine or Amlodipine) or vasodilators (Hydralazine) for sustained hypertension. Caution: ACE inhibitors (e.g., enalapril) are generally avoided during the acute phase due to hyperkalemia risk.
• Antibiotics: Penicillin or erythromycin is indicated ONLY if active streptococcal pharyngitis or impetigo is still documented upon presentation to eliminate carriage to contacts; antibiotics do NOT alter the clinical course of glomerulonephritis once immune complexes are formed.
• Surveillance for Hypertensive Encephalopathy:
  • Severe, acute hypertension can overcome cerebral autoregulation, causing cerebral edema.
  • Symptoms: Severe persistent headache, nausea, projectile vomiting, blurred vision, diplopia, papilledema, altered mental status, and generalized tonic-clonic seizures.
  • Nursing intervention: Place child on seizure precautions, monitor vitals every 15 minutes, and administer emergency IV antihypertensives (Nicardipine or Labetalol infusion).